Legal & General Group Plc - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$820,000
+32.3%
65,954
+42.1%
0.00%0.0%
Q3 2016$620,000
+75.1%
46,419
-3.6%
0.00%
Q2 2016$354,000
+41.0%
48,134
+22.5%
0.00%
Q1 2016$251,000
-1.2%
39,309
-2.5%
0.00%
Q4 2015$254,000
+21.0%
40,302
+12.4%
0.00%
Q3 2015$210,000
-28.3%
35,8580.0%0.00%
Q2 2015$293,000
+8.9%
35,858
+12.5%
0.00%
Q1 2015$269,000
+52.8%
31,881
+24.8%
0.00%
Q4 2014$176,000
+18.1%
25,540
-3.2%
0.00%
Q3 2014$149,00026,3880.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders